Switching costs in competitive health insurance markets: The role of insurers' pricing strategies.

Swiss health care systems bundling consumer inertia low-price supplementary product managed competition pricing supplementary insurance switching costs

Journal

Health economics
ISSN: 1099-1050
Titre abrégé: Health Econ
Pays: England
ID NLM: 9306780

Informations de publication

Date de publication:
09 2020
Historique:
received: 09 07 2019
revised: 16 03 2020
accepted: 11 05 2020
pubmed: 17 6 2020
medline: 19 8 2021
entrez: 17 6 2020
Statut: ppublish

Résumé

Our article deals with pricing strategies in Swiss health insurance markets and focuses on the relationship between basic and supplementary insurance. We analyzed how firms' pricing strategies (i.e., pricing of basic and supplementary products) can create switching costs in basic health insurance markets, thereby preventing competition in basic insurance from working properly. More specifically, using unique market and survey data, we investigated whether firms use bundling strategies or supplementary products as low-price products to attract and retain basic insurance consumers. To our knowledge, this is the first paper to analyze these pricing strategies in the context of insurance/health insurance. We found no evidence of bundling in the Swiss setting. We did however observe that firms used low-price supplementary products that contributed to lock in consumers. A majority of firms offered at least one of such product at a low price. None offered low-price products in both basic and supplementary markets. Low-price insurance products differed across firms. When buying a low-price supplementary product, consumers always bought their basic contract from the same firm. Furthermore, those who opted for low-price supplementary products were less likely to declare an intention to switch basic insurance firms in the near future. This result was true for all risk category levels.

Identifiants

pubmed: 32542729
doi: 10.1002/hec.4111
pmc: PMC7496908
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

992-1012

Informations de copyright

© 2020 The Authors. Health Economics published by John Wiley & Sons Ltd.

Références

Eur J Health Econ. 2016 Apr;17(3):339-53
pubmed: 25820635
Health Econ. 2010 Oct;19(10):1142-65
pubmed: 19653329
Health Aff (Millwood). 1996 Spring;15(1):143-51
pubmed: 8920578
Health Econ. 2020 Sep;29(9):992-1012
pubmed: 32542729
J Health Econ. 2002 Jan;21(1):89-116
pubmed: 11845927
Eur J Health Econ. 2012 Feb;13(1):51-62
pubmed: 20862510
Health Econ. 2009 Nov;18(11):1339-56
pubmed: 19267356
Health Aff (Millwood). 2000 May-Jun;19(3):158-64
pubmed: 10812794
J Health Econ. 2006 Jul;25(4):762-81
pubmed: 16704882

Auteurs

Karine Lamiraud (K)

Department of Economics, ESSEC Business School and Thema, Cergy, France.

Pierre Stadelmann (P)

Service de la Santé publique, Etat de Vaud, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH